Uterus

Djordjevic B, Gien LT, Covens A, Malpica A, Khalifa MA. Polypoid or
non-polypoid? A novel dichotomous approach to uterine carcinosarcoma. Gynecol
Oncol. 2009 Oct;115(1):32-6. Epub 2009 Jul 28. PubMed PMID: 19640575.

Bernardini MQ, May T, Khalifa MA, Bland AE, Nofech-Mozes S, Berchuck A,
Covens A, Havrilesky L. Evaluation of two management strategies for preoperative
grade 1 endometrial cancer. Obstet Gynecol. 2009 Jul;114(1):7-15. PubMed PMID:
19546752.

Nofech-Mozes S, Khalifa MA, Ismiil N, Saad RS, Hanna WM, Covens A, Ghorab Z.
Immunophenotyping of serous carcinoma of the female genital tract. Mod Pathol.
2008 Sep;21(9):1147-55. Epub 2008 Jun 20. PubMed PMID: 18567994.

Nofech-Mozes S, Ackerman I, Ghorab Z, Ismiil N, Thomas G, Covens A, Khalifa
MA. Lymphovascular invasion is a significant predictor for distant recurrence in
patients with early-stage endometrial endometrioid adenocarcinoma. Am J Clin
Pathol. 2008 Jun;129(6):912-7. PubMed PMID: 18480008.

Nofech-Mozes S, Ghorab Z, Ismiil N, Ackerman I, Thomas G, Barbera L, Covens
A, Khalifa MA. Endometrial endometrioid adenocarcinoma: a pathologic analysis of
827 consecutive cases. Am J Clin Pathol. 2008 Jan;129(1):110-4. PubMed PMID:
18089496.

Ismiil N, Rasty G, Ghorab Z, Nofech-Mozes S, Bernardini M, Ackerman I, Thomas
G, Covens A, Khalifa MA. Adenomyosis involved by endometrial adenocarcinoma is a
significant risk factor for deep myometrial invasion. Ann Diagn Pathol. 2007
Aug;11(4):252-7. PubMed PMID: 17630108.

Ismiil ND, Rasty G, Ghorab Z, Nofech-Mozes S, Bernardini M, Thomas G,
Ackerman I, Covens A, Khalifa MA. Adenomyosis is associated with myometrial
invasion by FIGO 1 endometrial adenocarcinoma. Int J Gynecol Pathol. 2007
Jul;26(3):278-83. PubMed PMID: 17581412.

Dubé V, Macdonald D, Allingham-Hawkins DJ, Kamel-Reid S, Colgan TJ. Vanishing endometrial carcinoma. Int J Gynecol Pathol. 2007 Jul;26(3):271-7. PubMed PMID: 17581411.

Dubé V, Grigull J, DeSouza LV, Ghanny S, Colgan TJ, Romaschin AD, Siu KW.
Verification of endometrial tissue biomarkers previously discovered using mass
spectrometry-based proteomics by means of immunohistochemistry in a tissue
microarray format. J Proteome Res. 2007 Jul;6(7):2648-55. Epub 2007 Jun 7. PubMed
PMID: 17552551.

DeSouza LV, Grigull J, Ghanny S, Dubé V, Romaschin AD, Colgan TJ, Siu KW.
Endometrial carcinoma biomarker discovery and verification using differentially
tagged clinical samples with multidimensional liquid chromatography and tandem
mass spectrometry. Mol Cell Proteomics. 2007 Jul;6(7):1170-82. Epub 2007 Mar 19.
PubMed PMID: 17374602.

Saad RS, Jasnosz KM, Tung MY, Silverman JF. Endoglin (CD105) expression in
endometrial carcinoma. Int J Gynecol Pathol. 2003 Jul;22(3):248-53. PubMed PMID:
12819391.

Khalifa MA, Patterson-Cobbs G, Hansen CH, Hines JF, Johnson JC. The
occurrence of endometrial adenocarcinoma in a patient with basal cell nevus
syndrome. J Natl Med Assoc. 1997 Aug;89(8):549-52. PubMed PMID: 9264223; PubMed Central PMCID: PMC2568122.

Khalifa MA, Hansen CH, Moore JL Jr, Rusnock EJ, Lage JM. Endometrial stromal
sarcoma with focal smooth muscle differentiation: recurrence after 17 years: a follow-up report with discussion of the nomenclature. Int J Gynecol Pathol. 1996
Apr;15(2):171-6. PubMed PMID: 8786208.

Khalifa MA, Mannel RS, Haraway SD, Walker J, Min KW. Expression of EGFR,
HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas. Gynecol Oncol. 1994 Apr;53(1):84-92. PubMed PMID:
7909788.

Khalifa MA, Abdoh AA, Mannel RS, Haraway SD, Walker JL, Min KW. Prognostic utility of epidermal growth factor receptor overexpression in endometrial
adenocarcinoma. Cancer. 1994 Jan 15;73(2):370-6. PubMed PMID: 8293402.